Shots: The P-lll GALACTIC-HF study involves the assessing of Omecamtiv mecarbil (25mg, bid with the maintenance dose of 50 mg, 37.5mg, or 25mg, bid) vs PBO in 8,256 patients with […]readmore
Tags : Omecamtiv Mecarbil
Shots: The P-III METEORIC-HF study involves assessing of omecamtiv mecarbil (25/50 mg, bid) vs PBO in 270 patients in the ratio (2:1) on exercise capacity as determined by cardiopulmonary exercise […]readmore